B08_SOL_Exhibit_1_Performance_Work_Statement.pdf

U.S. Department of the Interior

Interior Business Center

Human Resources Directorate

Security, Drug and Alcohol Testing Division

Drug & Alcohol Testing Branch

Laboratory Analysis Services

Performance Work Statement

Exhibit 1

SECTION 1: BACKGROUND

On April 27, 1988, the Department of the Interior (DOI) established their Drug-Free Workplace Program which created a need for drug testing services; including the analysis of urine specimens to detect the presence of illegal drugs.

After the inception of the program, DOI allowed other federal agencies, organizations, commissions, and/or foundations to utilize its laboratory contract to accomplish their own Drug- Free Workplace Program objectives. This allowed most of the Government’s needs to be consolidated, resulting in lower prices being secured by the Government and reduced the number of federal acquisition offices being involved in the award and maintenance of the contract.

Approximately 70 federal entities herein referred to as participating Agencies or Government, will be obtaining services from this award.

The solicitation is issued by DOI and the participating Agencies shall be identified at the time of contract award. DOI reserves the right to add additional or delete agencies via modification after contract award.

1.1. Scope

The Government conducts drug testing as required and regulated by the Department of Health & Human Services (HHS) and the Department of Transportation (DOT) to detect the presence of marijuana (THC), cocaine, opioids, amphetamines and phencyclidine (PCP) (and other illicit or abused substances) and to deter illegal drug use by their employees. Commonly needed test types include pre-employment, random, reasonable suspicion/cause, post-accident, return to duty, and follow-up (or for other reasons as needed)

This Indefinite Delivery/Indefinite Quantity (ID/IQ) contract may be used by DOI and the Agencies. DOI reserves the right to add additional or remove agencies via modification after contract award.

The contractor will be strongly linked to DOI’s other contractor that provides Scheduling, Collections, and Medical Review Officer services. The two companies shall have daily contact, work closely together, and rely on one another to help DOI and the Agencies accomplish their program needs.

Due to statutory chain of custody requirements, the scheduling, specimen collection, and Medical Review Officer (MRO) requirement (Collection & MRO) must be provided under a contract separate from the Laboratory Analysis Services requirement. Therefore, two separate contracts will be solicited and awarded to two different contractors.

SECTION 2: REQUIREMENTS

2.1. Laboratory Analysis Procedures

The Contractor shall provide to the Government all labor, materials, and equipment necessary for the laboratory analysis of specimens. The Contractor must be an HHS-Certified Lab for Urine and Oral Fluid Drug Testing for Federal Agencies and meet all the standards/requirements set forth in HHS mandatory guidelines. The Contractor shall perform testing of bodily fluids (whichever specimens have been approved by HHS for testing) for the presence of at least the 5-drug panel or the current HHS approved panel.

The Contractor shall also provide non-regulated testing. This testing shall be performed on bodily fluids (whichever specimens have been approved by HHS for testing) for the presence of at least the 5-drug test panel or the current HHS approved panel. Non-regulated testing should mirror HHS and DOT testing but take place on a non-federal CCF.

2.2. Reporting Results

The laboratory shall report test results to DOI’s Medical Review Officer (MRO) on average of 24 hours after receipt of the specimen by the laboratory. Except as otherwise provided in this statement of work, the laboratory shall report as negative all specimens which are negative on the initial test or negative on the confirmatory test within 24 hours after receipt of the specimen.

Only specimens confirmed positive shall be reported positive for a specific drug and reported to the Medical Review Officer within an average of 48-72 hours after receipt of specimen.

2.3. Quantization of Results

The MRO may request from the laboratory and the laboratory shall provide quantitation of test results.

2.4. Transmission of Results to Medical Review Officer, DOI, and Agencies For all test results, an HHS certified laboratory may fax, courier, mail, or electronically transmit a legible image or copy of the completed Federal CCF or unregulated testing CCF, and/or forward a computer generated electronic report (preferably whichever is fastest and most secure).

The computer-generated report must contain sufficient information to ensure that the test result is properly associated with the custody and control form that the MRO received from the collector.

Statistical summary reports should be provided per the HHS Mandatory Guidelines.

2.5. Record Retention

The laboratory shall retain records per the HHS Mandatory Record Retention Guidelines.

2.6. Long-Term Storage

The laboratory shall retain specimens per the HHS Mandatory Record Retention Guidelines.

2.7. Retesting of a Specimen

The laboratory will have established procedures when split specimen must be tested. These procedures should be in accordance with the HHS Mandatory Guidelines.

2.8. Subcontracting

Drug testing laboratories shall not subcontract and shall perform all work with their own personnel and equipment unless otherwise authorized by the agency. The laboratory must be capable of performing testing for the five classes of drugs (marijuana, cocaine, opioids, phencyclidine, and amphetamines) using the methods stipulated in the HHS Mandatory Guidelines.

SECTION 3: LABORATORY FACILITIES

3.1. Laboratory Facilities shall comply with applicable provisions of any Federal and State licensure requirements. Laboratories certified in accordance with HHS Guidelines (the National Laboratory Certification Program) shall have the capability, at the same laboratory premises, of performing initial and confirmatory tests for each drug or metabolite for which service is offered.

The National Laboratory Certification Program includes comprehensive performance testing and laboratory inspection programs.

3.2. Inspections

Any Federal agency utilizing the laboratory, or any organization performing laboratory certification on behalf of the HHS’’ Secretary may reserve the right to inspect the laboratory at any time. Agency contracts with laboratories for drug testing, as well as contracts for collection site services, shall permit the agency to conduct inspections.

3.3. Documentation

The contractor shall maintain documentation in accordance with HHS guidelines.

3.4. Personnel Available to Testify at Proceedings

A laboratory shall have qualified personnel available to testify in an administrative or disciplinary proceeding against a Federal employee when that proceeding is based on positive results reported by the laboratory.

3.5. Restrictions

The laboratory shall not enter into any relationship with an agency's MRO that may be construed as a potential conflict of interest or derive any financial benefit by having an agency use a specific MRO.

3.6. Electronic Custody and Control Form (eCCF)

The laboratory must be certified by HHS to utilize eCCF.

3.7. Expert Testimony

The Government may require the Contractor to make its personnel available to the participating agencies as requested to provide expert advice and testimony in support of any administrative and/or judicial/court action or other proceedings. The Contractor shall provide any documentation necessary to support the testimony of the expert witness(es). The qualifications and training records of all persons designated as expert witnesses, and the qualifications and training records of all persons testing the samples for which testimony is requested, shall be made available on each occasion testimony is requested. The laboratory director shall be able to qualify in court as an expert witness, and preferably shall have qualified in previous judicial/administrative hearings as an expert witness. Experts shall be able to provide evidence on the validity and reliability of the tests and procedures used; including custody and control, transportation, testing, storage, and records. Technologists and other personnel shall be available as requested by participating agencies to testify concerning actual procedures used, tests conducted, or to verify custody and control documents.

The testimony price shall be the rate proposed by the Contractor. Travel and per diem rates will be based on Federal Travel Regulations.

3.8. Litigation Package

In support of proposed or pending challenges to drug test results, Federal agencies may request testing documents packages (litigation packages). Litigation package information should include a laboratory summary report; affidavit; custody and control documents; screening and confirmation test printouts; laboratory certifying documents; certifying scientist and technical staff qualifications. Litigation packages shall be provided within 30 business days from the date of request by the Federal agency or specified in each individual task order.

3.9. Prepare/Ship Aliquot/Split Specimen to a Second Certified Laboratory The Contractor shall prepare and ship aliquot and split specimens to a second certified laboratory, as required. The Medical Review Officer, Contracting Officer’s Representative, Agency Drug Program Manager, or donor may request this service. This procedure may be requested depending on whether the donor challenges the result of the specimen. All proper procedures and controls shall be followed to maintain custody and control.

3.10. Cancelled Specimens

Some specimens sent to and received by the Contractor may not be able to be analyzed due to problems with the specimen bottles; shipping containers and/or chain of custody. The Contractor shall have the ability to recover funds for their administrative costs incurred for receiving and processing specimens that are not subsequently tested.

3.11. Oral Fluid Collection Device

The contractor shall provide a single use device that has been cleared by the Food and Drug Administration for the collection of oral fluid and meets HHS Mandatory Guidelines.

3.12. Split Urine Specimen Kits

The contractor shall provide Split Urine Specimen Bottles/Box Kit(s). The Split Urine Specimen Bottles/Box Kit shall include: one sealed 120ml+ plastic urine specimen catch cup with temperature strip attached; two sealed 45ml+ plastic urine specimen transfer bottles; one 4” by 8” inch plastic transport pouch with two separate sections and double edged tape seal; one transport pouch security seal.

3.13. 5-Part Federal Drug Testing Custody and Control Form – No Printing The contractor shall provide 5-Part Federal Drug Testing Custody and Control Forms, with no printing in the Step #’s. The name of the laboratory must be printed on forms.

3.15. 5-Part Federal Drug Testing Custody and Control Form – Pre-printed

The contractor shall provide 5-Part Federal Drug Testing Custody and Control Forms, with preprinting in the Step #’s. Each agency will specify the information to be preprinted. Name of lab must be printed on forms.

3.16. Prepaid Shipping Labels

The contractor shall provide overnight express prepaid shipping labels based on specific request by Agency.

3.16. Screening Tests for Other Schedule I and II Drugs

The contractor shall perform screening tests for other Schedule I and II drugs of the Controlled Substances Act. Testing methodology and techniques as recommended by HHS. Procedures for processing are same as for other drugs under this contract including: handling, shipping, delivery, chain of custody, security, reporting, etc. Cutoff levels for positives shall be provided by Contracting Officer’s Representative or Agency Drug Program Manager.

3.17. Confirmation Tests for Other Schedule I and II Drugs

The contractor shall perform confirmation tests for other Schedule I and II drugs of the Controlled Substances Act. Testing methodology and techniques as recommended by the HHS Procedures for processing are same as for other drugs under this contract including: handling, shipping, delivery, custody and control, security, reporting, etc. Cutoff levels for positives shall be provided by Contracting Officer’s Representative or Agency Drug Program Manager.

3.18. Automated Data Processing

The Contractor shall be able to provide and perform all of the automated Lab Drug Testing System requirements provided in this Statement of Work at the task order level (if required).

3.19. Assessment and Authorization

The Contractor is required to comply with the security and privacy requirements summarized in this section and identified in the attached DOI Baseline Compliance, NIST standards and the DOI Security Control Standards established using the NIST SP 800-53. All applicable security and privacy controls identified herein, and in the DOI Security Control Standards, shall be assessed in accordance with the NIST SP 800-53 (current revision)., Guide for Assessing the Security Controls in Federal Information Systems and Organizations; Building Effective Assessment Plans.

The level of compliance with the required minimum baseline security and privacy controls are determined by the Government to ensure a level of trust with the service provider and that the risk from using external services is at an acceptable level to the DOI authorizing official.

Information Systems processing Government data must be assessed prior to going into production and annually thereafter and reaccredited every three years or whenever there is a major change that affects security. The contractor must follow the most current releases of the following: National Institute of Standards and Technology Special Publication 800-37, 800-18, Rev.1, 800-30, 800-60 vol. 1 and vol. 2, 800-53, 800-53a Federal Information Processing Standard 199 and Federal Information Processing Standard 200, the associated DOI guides/templates, and the DOI Privacy Impact Assessment. The government will reserve the right to conduct the Security Assessment, using either government personnel or an independent contractor. The contractor shall take appropriate and timely action to correct or mitigate any weaknesses discovered during such testing, generally at no additional cost. The Authorizing Official (AO) for the system will be the official identified in DOI Secretarial Order No. 3255.

Information Technology Security Artifacts Required for Outsourcing IT Services / Systems The following artifacts are to be provided to determine the contractor’s readiness to complete the DOI security evaluation and testing process in support of an accreditation.

1. Information System Access Control Policy and Procedures

2. Access control mechanisms in place for the system

3. Least Privilege process in place

4. Separation of duties mechanism in place

5. Information System / Network Identification Elements

6. Overall System / Network Description

7. Architectural Diagrams of Network and/or Information Technology Components

8. Architectural Diagram of System Specific Components

9. List of all network perimeter devices (i.e., firewalls, intrusion detection system etc.)

10. List of components associated with DOI information system (servers, applications, version numbers).

11. List of any system interconnections / interfaces with other systems.

12. List of Data elements to be processed, stored and/or transmitted by information system.

13. List of facility physical security mechanisms, to include physical security surrounding area where DOI information system will be housed.

14. Contingency Planning Capabilities

15. Description of current contingency plans in place (i.e., alternate sites, locations, agreements, etc.)

16. Provide disaster recovery procedures in place for facility, network or components of network.

17. Provide backup and recovery procedures that in place for information system or network.

18. IT Change / Configuration Management Capabilities

19. List / Describe processes in place for Information Technology system changes.

20. List / Describe processes in place for patch management, hotfixes etc.

21. Describe processes in place for network / system configuration baseline management.

22. Other Agency Assessments

23. Provide any supporting documentation from other agency assessment and/or accreditations.

24. Any Applicable Federal or Government Agency Requirements

25. Provide a list of any federal or government agency requirements that are applicable to this company.

26. Information Technology Security Artifacts Required for Outsourcing IT Services / Systems –

DOI

4.0. OTHER CONSIDERATIONS

4.1. Contractor Location

Custom software development and outsourced operations must be located in the United States to the maximum extent practical. If such services are proposed to be performed abroad, the contractor must provide an acceptable security plan specifically to address mitigation of the resulting problems of communication, control, data protection, and so forth.

4.2. Applicable Standards

Contractors must follow the DOI System Development Life Cycle National Institute Standards and Technology Special Publication 800-64.

4.3. Security Categorization

The Contractor must use the Federal Information Processing Standard 199 and the National Institute Standards and Technology Special Publication 800-60 for all systems to determine information types and security categorization based on mission impact, data sensitivity, risk level, and bureau / departmental / national criticality.

4.4. Data Rights

In accordance with Federal Acquisition Regulation (FAR) clause 52.227-14, Rights in Data – General, the Government shall have unlimited rights for all data delivered under task orders issued against this contract unless provided for otherwise for special works data, in accordance with FAR Clause 52.227-17, Rights in Data -- Special Works.

4.5. Independent Verification and Validation

Software updates must be independently verified and validated prior to being moved into production. Associated costs for updates shall be borne by contractor.

4.6. Incident Reporting

The contractor must report computer security incidents affecting DOI data or systems in accordance with the DOI Computer Incident Response Guide. The contractor shall maintain intrusion detection and/or protection systems to detect attacks against the system and report them to the DOI assigned Information System Security Officer (ISSO) per the timelines published in the DOI Incident Response Policy/Procedures.

4.7. Annual Assessment

The contractor must participate in an annual self-assessment in accordance with annual DOI guidance on all information systems in production. DOI issues guidance for the self-assessment annually. Guidance will be provided to the contractor on an annual basis when issued, usually in the second quarter of each fiscal year. Both hard copy and electronic copies of the assessment will be provided to the COR. The government will reserve the right to conduct such an assessment using government personnel or another contractor. The contractor shall take appropriate and timely action to correct or mitigate any weaknesses discovered during such testing, generally at no additional cost.

4.8. Vulnerability Analysis

All systems must be scanned monthly with a vulnerability analysis tool that is compatible with the software in use by the Office of the Chief Information Officer at the time. All “safe” or “non-destructive” checks must be turned on. An electronic copy of each report and session data will be provided to the Contracting Officer’s Representative. At least annually, all high and moderate risk impact systems and systems accessible from the Internet must be independently penetration tested. Electronic and hard copy reports of penetration test results will be provided to the Contracting Officer’s Representative. The government will reserve the right to conduct unannounced and prearranged independent vulnerability scans using government personnel or another contractor. The contractor will take appropriate and timely action to correct or mitigate any weaknesses discovered during such testing, generally at no additional cost.

4.8. Security Controls

Contractors will be required to ensure compliance with the security control requirements of the current version of National Institute Standards and Technology Special Publication 800-53, Rev.1, (http://csrc.nist.gov/publications/PubsSPs.html) which are applicable to the security categorization of the data or system. Federal Information Processing Standard 199 (http://csrc.nist.gov/publications/PubsFIPS.html) and the National Institute Standards and Technology Special Publication 800-60 (http://csrc.nist.gov/publications/PubsSPs.html) will be used to determine information types and security categorizations. The contractor shall utilize a robust security architecture to protect the Confidentiality, Integrity, and Availability of the DOI data contained within the system. This architecture shall include items such as, but not limited to, packet-filtering firewalls, intrusion detection/prevention systems security technical implementation guides for the secure installation of operating systems and applications, anti-virus/anti-malware, patch management, configuration and change management, and other tools, techniques, policies, procedures, and processes to secure the environment.

4.9. Contingency Plan

The contractor will submit a contingency plan in accordance with National Institute Standards and Technology Special Publication 800-34 and the DOI Contingency Plan Guide. The plan must be approved by the Contracting Officer’s Representative during the 30 day transition period or as specified in each individual task order. A copy of the annual test results will be provided to the Contracting Officer’s Representative upon completion of the test.

4.10. Section 508 of the Rehabilitation Act of 1973

The LAB DRUG TESTING SYSTEM shall comply with all requirements of Section 508 of the Rehabilitation Act of 1973. The Contractor shall ensure that the LAB DRUG TESTING SYSTEM meets the requirements for accessibility based on Section 508 of the Rehabilitation Act (29 U.S.C. 794d) for web and software applications. The Contractor shall certify in writing that the Contracting Officer’s Representative has been tested for accessibility and meets the Section 508 requirements. The Contractor shall describe how the proposed electronic and information technology deliverables meet at least the standards and criteria identified as applicable in the attached Government Product/Service Accessibility Template The following standards and criteria were determined to apply to the LAB DRUG TESTING SYSTEM:

36 CFR part 1194 Subpart B – Technical Standards 36 CFR part 1194 Subpart C – Functional Performance Criteria 36 CFR part 1194 Subpart D – Information, Documentation and Support

4.11. Interconnection Security Agreement

The Contractor and the DOI shall establish and maintain an Interconnection Security Agreement in accordance with National Institute Standards and Technology Special Publication 800-47 (http://csrc.nist.gov/publications/nistpubs/800-47/sp800-47.pdf). This Interconnection Security Agreement must be established prior to any production data transfer from DOI to the Contractor.

5.0. REQUIREMENTS OF CONTRACT EMPLOYEES

5.1. Drug Testing Of Employees

Not later than award of each individual task order, the Contractor shall establish an internal drug testing program to ensure that: (a) its employees involved in the receiving, processing, analyzing and reporting of results for urine specimens are drug-free; (b) such testing is done according to current Health and Human Services Guidelines. Testing requirements shall also apply to personnel at the backup laboratory.

5.2. Information Security

The Contractor shall keep all information in the strictest of confidence and take measures to protect it from unauthorized modification or destruction, said information being the sole property of the Government. The Contractor shall not publish, reproduce, or otherwise divulge such information in whole or in part, in any manner or form nor authorize or permit others to do so.

The Contractor shall take measures to restrict access to this information, while in their possession, to only those employees needing such information to perform the work provided herein. The Contractor shall immediately notify, telephonically and in writing, the Contracting Officer’s Representative of any event determined or suspected to become a breach of the requirement.

5.3. Contractor Personnel Files

Laboratory personnel files shall include: resume of training and experience; certification or license, if any; references; job descriptions; records of performance evaluation and advancement;

incident reports; and results of tests which establish employee competency for the position he or she holds, such as a test for color blindness, if appropriate.

5.4. Subcontracting

The laboratory shall perform all work required under these guidelines with its own personnel and equipment, unless otherwise authorized by the Contracting Officer or Contracting Officer’s Representative.

6.0. ADDITIONAL DELIVERABLES OR REQUIREMENTS

6.1. Licensing

The Contractor shall submit the name of a backup laboratory, Health and Human Services certified, at the time of contract award to be used in the event the Contractor loses their Health and Human Services certification. The backup laboratory shall agree to all the terms and conditions of this contract. Any additional expenses in utilizing the backup laboratory shall be incurred by the Contractor. If the backup laboratory loses their Health and Human Services certification, the Contractor shall subcontract with a new Health and Human Services certified backup laboratory meeting all of the requirements in this contract.

6.2. Reporting Requirements

Reporting Specimens With Fatal and Non-Fatal Errors The laboratory shall report all specimens with fatal and non-fatal errors to the collection contractor within four hours from the time the specimens are initially received and accessioned by the laboratory or as specified in each individual task order. The laboratory shall maintain and review a log of all fatal and non-fatal errors with the collection contractor via telephone on a daily basis. The log shall be made available to the agency Contracting Officer’s Representative upon request. The log shall be made available, in electronic format.

6.3. Other reporting requirements

If requested by the Contracting Officer’s Representative, the contractor shall provide other statistical information to assist with the smooth operation the Drug-Free Workplace Program.

6.4. Supplies

The Contractor shall, as requested, provide all labor, materials, and equipment, except that provided as Government Furnished, necessary to analyze the specimens collected.

Contractor will provide invoices per Federal Acquisition Regulations.

6.5. Training

The Contractor shall participate in two times yearly training and education conferences for the agencies, as requested by the agency Contracting Officer’s Representative and at no cost to the Government. Training to be held in major U.S. city locations (to be announced at later date).

Training to be provided by laboratory official(s) with expert knowledge of the requirements and operations of Federally certified labs. All expenses will be borne by the contractor.

7.0 TRANSITION

The contractor shall implement a transition to transfer services from the incumbent contractor as specified in each individual task order.

7.1. Transition In

The contractor shall implement a transition in period to transfer services from the incumbent contractor. The Contractor shall update the transition plan within five (5) days of any changes post award or as specified in each individual task order. During the transition in period, the contractor shall become familiar with standard operating procedures (SOPs), and assume the full execution of the requirements of this contract or any individual task orders awarded. During the transition in period, the contractor shall work closely with the current contractor to ensure a smooth transition of service and perform a joint inventory and audit of the transferred documentation/data. The successful offeror shall work closely with the incumbent contractor and coordinate to address the status and issues of transition. The contractor's program management structure, organization, and facilities shall be in place and fully operational at the end of the 30 day transition in period. At completion of the transition in period, the contractor shall have full responsibility for all requirements covered under this contract. The Government will provide the following information at the beginning of the Transition In period:

1. Contact information for Medical Review Officer contractor

2. Data file structure for result download to Medical Review Officer contractor

3. Addresses of customers who will need supplies delivered by the end of transition

4. Customer list with Agency address, point of contact, phone and email, and customer billing instructions

5. Contact information of DOI Drug & Alcohol Testing staff

6. Transition Out

7. Transition Out Plan

The Contractor shall prepare and deliver a Transition Out Plan. The Transition Out Plan shall include a description of the activities and schedule required to transition the laboratory services from the outgoing Contractor to the follow-on Contractor or Government agency. The plan shall include, but not be limited to, the following:

1. Transfer of Government Furnished Information as required,

2. Resource and staffing phase out,

3. Data transfer, and

4. Knowledge sharing and orientation

7.2. Deliverable: Transition Out Plan

Transition Execution When directed by the Government Contracting Officer, the Contractor shall execute the Transition Out Plan in order to:

Allow no disruption of laboratory services;

Accomplish a smooth transfer of daily operations and data transfer;

Transition all Government Furnished Information associated with this effort Ensure qualified personnel, with necessary skills, knowledge and clearances are available until the end of contract effort to perform laboratory services;

Collaborate and communicate with the Government during the transition period; and Identify and manage any risks associated with the transition out Transition Out Plan.

8.0. PERIOD OF PERFORMANCE

The period of performance of this contract is one-five year ordering period.

BASE: 01 October 2022 – 30 September 2023 Year One: 01 October 2023 – 30 September 2024 Year Two: 01 October 2024 – 30 September 2025 Year Three: 01 October 2025– 30 September 2026 Year Four: 01 October 2026 – 30 September 2027

9.0. GENERAL INFORMATION

9.1. Government Furnished Equipment and Information

Government Furnished Equipment and Information shall be specified in each individual task order.

9.2. Quality Assurance and Quality Control

The contractor shall have a quality assurance program which encompasses all aspects of the testing process including but not limited to specimen acquisition, chain of custody , security and reporting of results, initial and confirmatory testing, certification of calibrators and controls, and validation of analytical procedures. The performance characteristics (e.g., accuracy, precision, limit of detection limit of quantitation specificity) shall be documented for each test as appropriate. Validation of procedures shall document that carryover does not affect the donor’s specimen results. Periodic re-verification of analytical procedures is required. Quality assurance procedures shall be designed, implemented, and reviewed to monitor the conduct of each step of the testing process.

9.3. False Positives

Should a false positive error occur on a blind performance test sample or a blind performance test sample, the Contracting Officer and Contracting Officer’s Representative must be immediately notified verbally and later in writing; detailing the circumstances. HHS will also be notified and may take steps to remedy the situation.

9.4. Post Award Inspection

The Government reserves the right to conduct post award inspections of the contractor's facilities and/or require other evidence of technical, managerial, financial, and similar abilities to perform the work described in these specifications. These inspections may include testing quality control samples.

9.5. Government Points of Contact

Contracting Officer’s Representatives Alandra Harley-Stuckey U.S. Department of the Interior 202-208-6723 (Office) Alandra_R_Harley-Stuckey@ibc.doi.gov

Alison F. Stockdale U.S. Department of the Interior 202-208-6312 (Office) Alison_F_Stockdale@ibc.doi.gov

Contracting Officer Joseph Fusari U.S. Department of the Interior 202-631-4698 Joseph_Fusari@ibc.doi.gov mailto:Alandra_R_Harley-Stuckey@ibc.doi.gov mailto:Joseph_Fusari@ibc.doi.gov